home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
Post navigation
Previous Post
Previous
Peloton Therapeutics Inc. Presents Promising Data on First Inhibitor of HIF-2α for Renal Cell Carcinoma at 2015 AACR Annual Meeting
Next Post
Next
Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma